AstraZeneca Pharma India Ltd has informed BSE that a meeting of the Board of Directors of the Company will be held on May 26, 2022, inter alia:<BR><BR>1. To consider and approve the Audited Financial Results of the Company for the quarter and year ended March 31, 2022.<BR><BR>2. To recommend final dividend, if any, on the equity shares of the Company for the financial year ended March 31, 2022.<BR><BR>Further, the 'Trading Window' remains closed for all Designated Persons, from March 16, 2022 to May 28, 2022 (both days inclusive) in terms of AstraZeneca Pharma India Limited - Code of Conduct for Prevention of Insider Trading framed under Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015.
|